Literature DB >> 11069937

Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.

Y Wang1, R Xu, T Sasaoka, S Tonegawa, M P Kung, E B Sankoorikal.   

Abstract

The dopamine D2 receptor (D2) system has been implicated in several neurological and psychiatric disorders, such as schizophrenia and Parkinson's disease. There are two isoforms of the D2 receptor: the long form (D2L) and the short form (D2S). The two isoforms are generated by alternative splicing of the same gene and differ only by 29 amino acids in their protein structures. Little is known about the distinct functions of either D2 isoform, primarily because selective pharmacological agents are not available. We generated D2L receptor-deficient (D2L-/-) mice by making a subtle mutation in the D2 gene. D2L-/- mice (which still express functional D2S) displayed reduced levels of locomotion and rearing behavior. Interestingly, haloperidol produced significantly less catalepsy and inhibition of locomotor activity in D2L-/- mice. These findings suggest that D2L and D2S may contribute differentially to the regulation of certain motor functions and to the induction of the extrapyramidal side effects associated with the use of typical antipsychotic drugs (e.g., haloperidol). Quinpirole induced a similar initial suppression of locomotor activity in both D2L-/- and wild-type mice. In addition, the D2S receptor in the mutant mice functioned approximately equally well as did D2L as an impulse-modulating autoreceptor. This suggests that the functions of these two isoforms are not dependent on the formation of receptor heterodimers. Our findings may provide novel information for potentially developing improved antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069937      PMCID: PMC6773184     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.

Authors:  A J Silva; C F Stevens; S Tonegawa; Y Wang
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

2.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus.

Authors:  C L Chio; G F Hess; R S Graham; R M Huff
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

3.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

Authors:  B Giros; P Sokoloff; M P Martres; J F Riou; L J Emorine; J C Schwartz
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

4.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling.

Authors:  B F O'Dowd; M Hnatowich; J W Regan; W M Leader; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

Review 5.  Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Authors:  P Seeman; T Tallerico
Journal:  Mol Psychiatry       Date:  1998-03       Impact factor: 15.992

Review 6.  Molecular diversity of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

7.  The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins.

Authors:  S E Senogles
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

8.  [Influence of electroacupuncture and capsaicin treatment on AChE activity and [3H]-QNB binding sites in the spinal dorsal horn].

Authors:  R Xu; X Guan; C Wang
Journal:  Zhen Ci Yan Jiu       Date:  1996

9.  The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

10.  The dopamine D2 receptor: two molecular forms generated by alternative splicing.

Authors:  R Dal Toso; B Sommer; M Ewert; A Herb; D B Pritchett; A Bach; B D Shivers; P H Seeburg
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  65 in total

1.  Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice.

Authors:  Anh Hai Tran; Ryoi Tamura; Teruko Uwano; Tsuneyuki Kobayashi; Motoya Katsuki; Gen Matsumoto; Taketoshi Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

2.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 3.  Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

Authors:  Megan L Fitzgerald; Eli Shobin; Virginia M Pickel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-11       Impact factor: 5.067

4.  Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse.

Authors:  Derek B Oien; Andrea N Ortiz; Alexander G Rittel; Rick T Dobrowsky; Michael A Johnson; Beth Levant; Stephen C Fowler; Jackob Moskovitz
Journal:  J Neurochem       Date:  2010-03-31       Impact factor: 5.372

Review 5.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 6.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

7.  Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons.

Authors:  Norifumi Shioda; Yoshiki Imai; Yasushi Yabuki; Wataru Sugimoto; Kouya Yamaguchi; Yanyan Wang; Takatoshi Hikida; Toshikuni Sasaoka; Michihiro Mieda; Kohji Fukunaga
Journal:  J Neurosci       Date:  2019-08-01       Impact factor: 6.167

8.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

Review 9.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 10.  The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

Authors:  C P Ford
Journal:  Neuroscience       Date:  2014-01-23       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.